AMG 340 / Amgen 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AMG 340 / Amgen
TNB585.001, NCT04740034: A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma

Completed
1
42
US
AMG 340
Amgen
Metastatic Castration-resistant Prostate Cancer
06/24
06/24

Download Options